Revolution Medicines, Inc. (RVMDW) community

RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 3/30

$9.81+0.18 (+1.82%)

Close on Oct 30, 2026Market cap $41.00BP/E –Yield –

Community

Notes and questions about Revolution Medicines from other investors

No posts about RVMDW yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Revolution Medicines's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RVMDW.

Compare: RVMDW vs RLAY · RVMDW vs CRIS · RVMDW vs CRDF · RVMDW vs CLDI · RVMDW vs CERO

Company	Revenue	Growth
RLAY	$10.35M	+23.9%
CRIS	$4.31M	-62.2%
CRDF	$508.00K	-7.0%
RVMDW	$0	–
CLDI	–	–
CERO	–	–

Company

Next earnings (est.): Nov 4, 2026, after close
Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Fiscal year ends: December 31
Employees: 883
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1628171

Advertisement
300 × 250